These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34791066)

  • 1. Preliminary validation of muscle ultrasound in juvenile dermatomyositis (JDM).
    Mamyrova G; McBride E; Yao L; Shrader JA; Jain M; Yao J; Curiel RV; Miller FW; Harris-Love MO; Rider LG
    Rheumatology (Oxford); 2022 Apr; 61(SI):SI48-SI55. PubMed ID: 34791066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis.
    Maillard SM; Jones R; Owens C; Pilkington C; Woo P; Wedderburn LR; Murray KJ
    Rheumatology (Oxford); 2004 May; 43(5):603-8. PubMed ID: 14983103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance measurement of muscle T2, fat-corrected T2 and fat fraction in the assessment of idiopathic inflammatory myopathies.
    Yao L; Yip AL; Shrader JA; Mesdaghinia S; Volochayev R; Jansen AV; Miller FW; Rider LG
    Rheumatology (Oxford); 2016 Mar; 55(3):441-9. PubMed ID: 26412808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle MRI at the time of questionable disease flares in Juvenile Dermatomyositis (JDM).
    Abdul-Aziz R; Yu CY; Adler B; Bout-Tabaku S; Lintner KE; Moore-Clingenpeel M; Spencer CH
    Pediatr Rheumatol Online J; 2017 Apr; 15(1):25. PubMed ID: 28403889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Could ultrasound and muscle elastography be associated with clinical assessment, laboratory and nailfold capillaroscopy in juvenile dermatomyositis patients?
    de Andrade RLF; Mendonça JA; Piotto DP; Guimarães JB; Terreri MT
    Adv Rheumatol; 2023 Oct; 63(1):48. PubMed ID: 37803481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oropharyngeal dysphagia in juvenile dermatomyositis (JDM): an evaluation of videofluoroscopy swallow study (VFSS) changes in relation to clinical symptoms and objective muscle scores.
    McCann LJ; Garay SM; Ryan MM; Harris R; Riley P; Pilkington CA
    Rheumatology (Oxford); 2007 Aug; 46(8):1363-6. PubMed ID: 17569746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-body MRI in the assessment of disease activity in juvenile dermatomyositis.
    Malattia C; Damasio MB; Madeo A; Pistorio A; Providenti A; Pederzoli S; Viola S; Buoncompagni A; Mattiuz C; Beltramo A; Consolaro A; Ravelli A; Ruperto N; Picco P; Magnano GM; Martini A
    Ann Rheum Dis; 2014 Jun; 73(6):1083-90. PubMed ID: 23636654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term muscular outcome and predisposing and prognostic factors in juvenile dermatomyositis: A case-control study.
    Sanner H; Kirkhus E; Merckoll E; Tollisen A; Røisland M; Lie BA; Taraldsrud E; Gran JT; Flatø B
    Arthritis Care Res (Hoboken); 2010 Aug; 62(8):1103-11. PubMed ID: 20506141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging detection of occult skin and subcutaneous abnormalities in juvenile dermatomyositis. Implications for diagnosis and therapy.
    Kimball AB; Summers RM; Turner M; Dugan EM; Hicks J; Miller FW; Rider LG
    Arthritis Rheum; 2000 Aug; 43(8):1866-73. PubMed ID: 10943878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of magnetic resonance imaging in the diagnosis of juvenile dermato-myositis and polymyositis in Chinese children].
    Lai JM; Wu FQ; Zhou ZX; Yuan XY; Su GX; Li SN; Yan YC; Zhu J; Kang M
    Zhonghua Er Ke Za Zhi; 2016 Oct; 54(10):767-772. PubMed ID: 27784480
    [No Abstract]   [Full Text] [Related]  

  • 11. Submaximal Exercise Capacity in Juvenile Dermatomyositis after Longterm Disease: The Contribution of Muscle, Lung, and Heart Involvement.
    Berntsen KS; Tollisen A; Schwartz T; Kirkhus E; Aaløkken TM; Lund MB; Flatø B; Sjaastad I; Sanner H
    J Rheumatol; 2017 Jun; 44(6):827-834. PubMed ID: 28365577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dyslipidaemia in juvenile dermatomyositis: the role of disease activity.
    Kozu KT; Silva CA; Bonfá E; Sallum AM; Pereira RM; Viana VS; Borba E; Campos LM
    Clin Exp Rheumatol; 2013; 31(4):638-44. PubMed ID: 23557696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI of skeletal muscles in patients with idiopathic inflammatory myopathies: characteristic findings and diagnostic performance in dermatomyositis.
    Ukichi T; Yoshida K; Matsushima S; Kawakami G; Noda K; Furuya K; Kurosaka D
    RMD Open; 2019; 5(1):e000850. PubMed ID: 30997152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group.
    Lovell DJ; Lindsley CB; Rennebohm RM; Ballinger SH; Bowyer SL; Giannini EH; Hicks JE; Levinson JE; Mier R; Pachman LM; Passo MH; Perez MD; Reed AM; Schikler KN; Smith M; Zemel LS; Rider LG
    Arthritis Rheum; 1999 Oct; 42(10):2213-9. PubMed ID: 10524696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of myxovirus-resistance protein A: a possible marker of muscle disease activity and autoantibody specificities in juvenile dermatomyositis.
    Soponkanaporn S; Deakin CT; Schutz PW; Marshall LR; Yasin SA; Johnson CM; Sag E; Tansley SL; McHugh NJ; Wedderburn LR; Jacques TS
    Neuropathol Appl Neurobiol; 2019 Jun; 45(4):410-420. PubMed ID: 29770465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minor sperm abnormalities in young male post-pubertal patients with juvenile dermatomyositis.
    Moraes AJ; Pereira RM; Cocuzza M; Casemiro R; Saito O; Silva CA
    Braz J Med Biol Res; 2008 Dec; 41(12):1142-7. PubMed ID: 19148379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Otoferlin Expression in B Cells Is Associated with Muscle Weakness in Untreated Juvenile Dermatomyositis: A Pilot Study.
    Bukhari A; Khojah A; Marin W; Khramtsov A; Khramtsova G; Costin C; Morgan G; Ramesh P; Klein-Gitelman MS; Le Poole IC; Pachman LM
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative muscle ultrasonography in the follow-up of juvenile dermatomyositis.
    Habers GE; Van Brussel M; Bhansing KJ; Hoppenreijs EP; Janssen AJ; Van Royen-Kerkhof A; Pillen S
    Muscle Nerve; 2015 Oct; 52(4):540-6. PubMed ID: 25557638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome in patients with juvenile dermatomyositis: A case series.
    Chevalier G; Fakih O; Lhose A; Ballot-Schmit C; Prati C; Puzenat E; Aubin F
    Arch Pediatr; 2021 Aug; 28(6):475-479. PubMed ID: 34034928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid related protein induces muscle derived inflammatory mediators in juvenile dermatomyositis.
    Nistala K; Varsani H; Wittkowski H; Vogl T; Krol P; Shah V; Mamchaoui K; Brogan PA; Roth J; Wedderburn LR
    Arthritis Res Ther; 2013 Sep; 15(5):R131. PubMed ID: 24286299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.